AIG
PTCT icon

American International Group’s PTC Therapeutics PTCT Stock Holding History

American International Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-35,510
Closed -$1.03M – 2066
2024
Q1 		$1.03M Sell
35,510
-305
-0.9% -$8.54K ﹤0.01% 1280
2023
Q4 		$987K Buy
35,815
+462
+1% +$10.6K ﹤0.01% 1301
2023
Q3 		$792K Buy
35,353
+1,256
+4% +$46.7K 0.01% 1351
2023
Q2 		$1.39M Buy
34,097
+192
+0.6% +$9.39K 0.01% 1092
2023
Q1 		$1.64M Buy
33,905
+674
+2% +$30.8K 0.01% 1006
2022
Q4 		$1.27M Sell
33,231
-121
-0.4% -$5.03K 0.01% 1098
2022
Q3 		$1.67M Buy
33,352
+472
+1% +$23.1K 0.01% 986
2022
Q2 		$1.32M Sell
32,880
-1,604
-5% -$56.2K 0.01% 1088
2022
Q1 		$1.29M Sell
34,484
-2,428
-7% -$93.5K 0.01% 1194
2021
Q4 		$1.47M Sell
36,912
-1,104
-3% -$42.3K 0.01% 1216
2021
Q3 		$1.42M Sell
38,016
-903
-2% -$37.1K 0.01% 1229
2021
Q2 		$1.65K Buy
38,919
+2,901
+8% +$124K 0.01% 1229
2021
Q1 		$1.71K Buy
36,018
+95
+0.3% +$5.64K 0.01% 1191
2020
Q4 		$2.19K Sell
35,923
-1,031
-3% -$60.8K 0.01% 1035
2020
Q3 		$1.73M Sell
36,954
-840
-2% -$41.4K 0.01% 1009
2020
Q2 		$1.92M Buy
37,794
+2,035
+6% +$100K 0.01% 974
2020
Q1 		$1.59M Sell
35,759
-2,066
-5% -$104K 0.01% 949
2019
Q4 		$1.82M Buy
37,825
+1,662
+5% +$70.6K 0.01% 1040
2019
Q3 		$1.22M Sell
36,163
-252
-0.7% -$11K ﹤0.01% 1190
2019
Q2 		$1.64M Buy
36,415
+3,611
+11% +$143K 0.01% 1086
2019
Q1 		$1.24M Buy
32,804
+2,996
+10% +$101K ﹤0.01% 1210
2018
Q4 		$1.02M Sell
29,808
-229
-0.8% -$8.23K ﹤0.01% 1253
2018
Q3 		$1.41M Buy
30,037
+541
+2% +$22.4K ﹤0.01% 1231
2018
Q2 		$995K Buy
29,496
+3,865
+15% +$121K ﹤0.01% 1390
2018
Q1 		$694K Sell
25,631
-1,378
-5% -$34.9K ﹤0.01% 1489
2017
Q4 		$451K Buy
27,009
+422
+2% +$7.14K ﹤0.01% 1850
2017
Q3 		$532K Buy
26,587
+5,905
+29% +$116K ﹤0.01% 1726
2017
Q2 		$379K Buy
20,682
+202
+1% +$2.72K ﹤0.01% 1889
2017
Q1 		$202K Buy
20,480
+1,355
+7% +$16.4K ﹤0.01% 2178
2016
Q4 		$209K Sell
19,125
-50
-0.3% -$525 ﹤0.01% 2144
2016
Q3 		$269K Buy
19,175
+29
+0.2% +$236 ﹤0.01% 1982
2016
Q2 		$134K Sell
19,146
-678
-3% -$4.97K ﹤0.01% 2400
2016
Q1 		$128K Sell
19,824
-1
-0% -$17 ﹤0.01% 3203
2015
Q4 		$642K Sell
19,825
-35
-0.2% -$1.03K ﹤0.01% 1829
2015
Q3 		$530K Buy
19,860
+23
+0.1% +$984 ﹤0.01% 1972
2015
Q2 		$955K Buy
19,837
+4,467
+29% +$261K ﹤0.01% 1623
2015
Q1 		$935K Hold
15,370
– – ﹤0.01% 1665
2014
Q4 		$796K Buy
15,370
+854
+6% +$37.6K ﹤0.01% 1762
2014
Q3 		$639K Sell
14,516
-10
-0.1% -$313 ﹤0.01% 1922
2014
Q2 		$380K Buy
14,526
+7,991
+122% +$171K ﹤0.01% 2405
2014
Q1 		$171K Buy
6,535
+157
+2% +$4.22K ﹤0.01% 2972
2013
Q4 		$108K Buy
+6,378
New +$112K ﹤0.01% 3279

Other funds holding PTCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American International Group's PTCT Position: Q2 2024 in Review

American International Group sold out of PTC Therapeutics (PTCT) in Q2 2024, closing a stake of 35,510 shares — an estimated $1.03M sold.

American International Group first reported a position in PTCT in Q4 2013 and held it in 42 quarters. The position peaked at $1.92M in Q2 2020. 198 funds tracked by Wall St. Rank hold PTCT as of Q2 2024.

  • American International Group reported no remaining PTC Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 35,510 PTC Therapeutics shares in Q2 2024, an estimated $1.03M.
  • American International Group first reported a position in PTC Therapeutics in Q4 2013 and held it in 42 quarters.
  • American International Group's PTC Therapeutics position peaked at $1.92M in Q2 2020.
  • 198 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.